Vascular hemostasis and brain embolism

Brain Embolism

Volumn , Issue , 2006, Pages 243-258

  del Zoppo, Gregory J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35148880946     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (90)

1. Mabuchi T, Lucero J, Feng A, Koziol JA, del Zoppo GJ. Focal cerebral ischemia preferentially affects neurons distant from their neighboring microvessels. J. Cerebral Blood Flow Metab 2005; 25:257-266.
2. Balabanov R, Dore-Duffy P. Role of the CNS microvascular pericyte in the blood-brain barrier. J Neurosci Res 1998; 53:637-644.
3. Ramsauer M, Krause D, Dermietzel R. Angiogenesis of the blood-brain barrier in vitro and the function of cerebral pericytes. FASEB 2002; 16:1274-1276.
4. Bernstein JJ, Getz R, Jefferson M, Kelemen M. Astrocytes secrete basal lamina after hemisec-tion of rat spinal cord. Brain Res 1985; 327:135-141.
5. Ard MD, Faissner A. Components of astrocytic extracellular matrix are regulated by contact with axons. Ann N Y Acad Sci 1991; 633:566-569.
6. Tagami M, Yamagata K, Fujino H, Kubota A, Nara Y, Yamori Y. Morphological differentiation of endothelial cells co-cultured with astrocytes on type-I or type-IV collagen. Cell Tissue Res 1992; 268:225-232.
7. Webersinke G, Bauer H, Amberger A, Zach O, Bauer HC. Comparison of gene expression of extracellular matrix molecules in brain microvascular endothelial cells and astrocytes. Biochem Biophys Res Commun 1992; 189:877-884.
8. Nagano N, Aoyagi M, Hirakawa K. Extracellular matrix modulates the proliferation of rat astrocytes in serum-free culture. GLIA 1993; 8:71-76.
9. Micic D, Swink M, Micic J, Klatzo I, Spatz M. The ischemic and postischemic effect on the uptake of neutral amino acids in isolated cerebral capillaries. Experientia 1993; 15:625-626.
10. Spatz M, Micic D, Mrsulja BB, Klatzo I. Cerebral microvessels as mediators of cerebral transport. Adv Neurol 1978; 20:189-196.
11. del Zoppo GJ, Yu J-Q, Copeland BR, Thomas WS, Schneiderman J, Morrissey J. Tissue factor localization in non-human primate cerebral tissue. Thromb Haemost 1992; 68:642-647.
12. del Zoppo G. Antithrombotic interventions in cerebrovascular disease. In: Loscalzo J, Schafer A, eds. Thrombosis and Hemorrhage. Philadelphia: Lippincott, Williams & Wilkins, 2003:1003-1029.
13. Bloom AL, Thomas DP. Haemostasis and Thrombosis. Edinburgh: Churchill-Livingstone, 1987.
14. Smith-Swintosky VL, Zimmer S, Fenton IJW, Mattson MP. Opposing actions of thrombin and protease nexin-1 on amyloid beta-peptide toxicity and on accumulation of peroxides and calcium in hippocampal neurons. J Neurochem 1995; 65:1415-1418.
15. Festoff BW, Smirnova IV, Ma J, Citron BA. Thrombin, its receptor and protease nexin I, its potent serpin, in the nervous system. Semin Thromb Hemost 1996; 22:267-271.
16. Cunningham DD, Donovan FM. Regulation of neurons and astrocytes by thrombin and protease nexin-1. Relationship to brain injury. Adv Exp Med Biol 1997; 425:67-75.
17. Gimbrone MA Jr. Nature's blood container. In: Gimbrone MA Jr, ed. Vascular Endothelium in Hemostasis and Thrombosis. Edinburgh: Churchill-Livingstone, 1986:1-13.
18. Feinberg WM, Bruck DC, Ring ME, Corrigan JJ Jr. Hemostatic markers in acute stroke. Stroke 1989; 20:592-597.
19. Hart RG, Kanter MC. Hematologic disorders and ischemic stroke: a selective review. Stroke 1990; 21:1111-1121.
20. Landi G, D'Angelo A, Boccardi E, Candelise L, Mannucci PM, Orazio EN, Morahito A. Hyper-coagulability in acute stroke: prognostic significance. Neurology 1987; 37:1667-1671.
21. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988; 19:547-554.
22. Bogousslavsky J, Cachin C, Regli F, Despland PA, Van Melle G, Kappenberger L. Cardiac sources of embolism and cerebral infarction-clinical consequences and vascular concomitants: the Lausanne Stroke Registry. Neurology 1991; 41:855-859.
23. Lindgren A, Roijer A, Norrving B, Eskilsson J, Wallin L, Johansson BB. Carotid artery and heart disease in subtypes of cerebral infarction. Stroke 1994; 25:2356-2362.
24. Czlonkowska A, Ryglewicz D, Weissbein T, Baranska-Gieruszczak M, Hier DB. A prospective community-based study of stroke in Warsaw, Poland. Stroke 1994; 25:547-551.
25. Moulin T, Tatu L, Crepin-Leblond T, Chavot D, Berges S, Rumbach T. The Besancon Stroke Registry: an acute stroke registry of 2,500 consecutive patients. Eur Neurol 1997; 38:10-20.
26. del Zoppo GJ. Microvascular responses to cerebral ischemia/inflammation. Ann N Y Acad Sci 1997; 823:132-148.
27. Neuropsychiatric Manifestations of Systemic Lupus Erythematosus. 1st ed. New York: New York Academy of Sciences, 1997.
28. del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 2003; 23:879-894.
29. Okada Y, Copeland BR, Mori E, Tung M-M, Thomas WS, del Zoppo GJ. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 1994; 25:202-211.
30. Okada Y, Copeland BR, Fitridge R, Koziol JA, del Zoppo GJ. Fibrin contributes to microvas-cular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke 1994; 25:1847-1854.
31. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang C-M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991; 22:1276-1284.
32. Mori E, Chambers JD, Copeland BR, Arfors K-E, del Zoppo GJ. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia. Stroke 1992; 23:712-718.
33. Ames A, Wright LW, Kowada M, Thurston JM, Majors G. Cerebral ischemia: II. The no-reflow phenomenon. Am J Pathol 1968; 52:437-453.
34. Levin EG, del Zoppo GJ. Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol 1994; 144:855-861.
35. Choudri TF, Hoh BL, Zerwes HG, Prestigiacomo CJ, Kim SC, Connolly E, et al. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest 1998; 102:1301-1310.
36. Abumiya T, Fitridge R, Mazur C, Copeland BR, Koziol JA, Tschopp JF, et al. Integrin αIIbß3 inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia. Stroke 2000; 31:1402-1410.
37. Fisher CM, Adams RD. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 1951; 10:92-94.
38. del Zoppo GJ, Ferbert A, Otis S, Brückmann H, Hacke W, Zyroff J, et al. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: A pilot study. Stroke 1988; 19:307-313.
39. Ogata J, Yutani C, Imakita M, Ishibashi-Ueda H, Saku Y, Minematsu K et al. Hemorrhagic infarct of the brain without a reopening of the occluded arteries in cardioembolic stroke. Stroke 1989; 20:876-883.
40. Jörgensen L, Torvik A. Ischaemic cerebrovascular diseases in an autopsy series. Part 2. Prevalence, location, pathogenesis, and clinical course of cerebral infarcts. J Neurol Sci 1969; 9: 285-320.
41. Pessin MS, Teal PA, Caplan LR. Hemorrhagic infarction: Guilt by association. AJNR 1991; 12:1123-1126.
42. Hamann GF, Okada Y, Fitridge R, del Zoppo GJ. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995; 26:2120-2126.
43. Heo JH, Lucero J, Abumiya T, Koziol JA, Copeland BR, del Zoppo GJ. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 1999; 19:624-633.
44. Hosomi N, Lucero J, Heo JH, Koziol JA, Copeland BR, del Zoppo GJ. Rapid differential endogenous plasminogen activator expression after acute middle cerebral artery occlusion. Stroke 2001; 32:1341-1348.
45. Chang DI, Hosomi N, Lucero J, Heo JH, Abumiya T, Mazar AP, et al. Activation systems for matrix metalloproteinase-2 are upregulated immediately following experimental focal cerebral ischemic. J Cereb Blood Flow Metab 2003; 23:1408-1419.
46. Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston LL Jr, del Zoppo GJ. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 2004; 35: 998-1004.
47. Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab 1996; 16:1373-1378.
48. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: Brain hemorrhage and management options. Stroke 1984; 15:779-789.
49. Babikian VL, Kase CS, Pessin MS, Norrving B, Gorelick PB. Intracerebral hemorrhage in stroke patients anticoagulated with heparin. Stroke 1989; 29:1500-1503.
50. Yamaguchi T, Minematsu K, Choki J, Ikeda M. Clinical and neuroradiological analysis of thrombotic and embolic cerebral infarction. Jpn Circ J 1984; 48:50-58.
51. Molinari GF. Pathogenesis of secondary brain hemorrhage after ischemia: Lessons from animal models... and a few from man, too! In: del Zoppo GJ, Mori E, Hacke W, eds. Thrombolytic Therapy in Acute Ischemic Stroke II. Heidelberg: Springer-Verlag, 1993:29-36.
52. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M, et al. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998; 29:4-11.
53. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32:78-86.
54. Levy DE, Brott TG, Haley EC Jr, Marler JR, Sheppard GL, Barsan W, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994; 25:291-297.
55. Larrue V, von Kummer R, del Zoppo GJ, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997; 28:957-960.
56. Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994; 25:298-303.
57. Goodnight SH, Kenoger G, Rapaport SJ, Patch MJ, Lee JA, Kurze T. Defibrination after brain tissue destruction. N Engl J Med 1974; 290:1043-1047.
58. del Zoppo GJ, Copeland BR, Harker LA, Waltz TA, Zyroff J, Hanson SR, et al. Experimental acute thrombotic stroke in baboons. Stroke 1986; 17:1254-1265.
59. Dougherty JH, Levy DE, Weksler BB. Platelet activation in acute cerebral ischemia. Lancet 1977; 3:821-824.
60. Iwamoto T, Kubo H, Takasaki M. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke 1995; 26:52-56.
61. Feinberg WM, Pearce LA, Hart RG, Cushman M, Cornell ES, Lip GY, et al. Markers of thrombin and platelet activity in patients with atrial fibrillation: Correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Stroke 1999; 30:2547-2553.
62. del Zoppo GJ, Becker KJ, Hallenbeck JM. Inflammation after stroke: is it harmful? Arch Neurol 2001; 58:669-672.
63. Keyeux A, Ochrymowicz-Bemelmans D, Charlier AA. Induced response to hypercapnia in the two-compartment total cerebral blood volume: Influence on brain vascular reserve and flow efficiency. J Cereb Blood Flow Metab 1995; 15:1121-1131.
64. Weeks JB, Todd MM, Warner DS, Katz J. The influence of halothane, isoflurane, and pentobar-bital on cerebral plasma volume in hypocapnic and normocapnic rats. Anesthesiology 1990; 73:461-466.
65. Seylaz J, Charbonne R, Nari K, VonEuw D, Borredon J, Kacem K, et al. Dynamic in vivo measurement of erythrocyte velocity and flow in capillaries and of microvessel diameter in therate brain by confocal laser microscopy. J Cereb Blood Flow Metab 1999; 19:863-870.
66. Pinard E, Engrand N, Seylaz J. Dynamic cerebral microcirculatory changes in transient forebrain ischemia in rats: involvement of type I nitric oxide synthase. J Cereb Blood Flow Metab 2000; 20:1648-1658.
67. Zulch K-J. The Cerebral Infarct: Pathology, Pathogenesis, and Computed Tomography. Heidelberg: Springer-Verlag, 1985.
68. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke 1995; 26:2219-2221.
69. del Zoppo GJ, von Kummer R, Hamann GF. Ischemic damage of brain microvessels: Inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry 1998; 65:1-9.
70. Feldmann E, Levine SR. Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options. Ann Neurol 1995; 37:S114-S130.
71. Weksler BB. Hematologic disorders and ischemic stroke. Curr Opin Neurol 1995; 8:38-44.
72. Panagariya A, Garg A, Sureka RK. Antiphospholipid antibody positive young stroke: an analysis of 12 cases. J Postgrad Med 2000; 46:258-261.
73. del Zoppo GJ. TIAs and the pathology of cerebral ischemia. Neurology 2004; 62:S15-S19.
74. Pascual M, Baumgartner JM, Bounameaux H. Stroke secondary to multiple spontaneous cholesterol emboli. Vasa 1991; 20:74-77.
75. Levin EG. Latent tissue plasminogen activator produced by human endothelial cells in culture: Evidence for an enzyme-inhibitor complex. Proc Natl Acad Sci USA 1983; 80:6804-6808.
76. Levin EG, Santell L. Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells. J Cell Biol 1987; 105:2543-2549.
77. Sappino AP, Madani R, Huarte J, Belin D, Kiss JZ, Wohlwend A, et al. Extracellular proteolysis in adult murine brain. J Clin Invest 1993; 92:679-685.
78. Keski-Oja J, Lohi J, Tuuttila A, Tryggvason K, Vartio T. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp Cell Res 1992; 202:471-476.
79. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, et al. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants. EMBO J 1997; 16:2319-2332.
80. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
81. Festoff BW, D'Andrea MR, Citron BA, Salcedo RM, Smirnova IV, Andrade-Gordon P. Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin. Mol Med 2000; 6:410-429.
82. Donovan FM, Pike CJ, Cotman CW, Cunningham DD. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neuroscience 1997; 17:5316-5326.
83. Malik AB, Fenton JWII. Thrombin-mediated increase in vascular endothelial permeability. Semin Thromb Hemost 1992; 18:193-199.
84. Vogt C, Vogt O. Erkrankungen des grosshirnrinde im lichte der topistik, pathoklise und pathoarchitektonik. J Psychol Neurol 1922; 28:1-89.
85. Pulsinelli WA. Selective neuronal vulnerability: Morphological and molecular characteristics. Prog Brain Res 1985; 63:29-37.
86. Calabresi P, Centonze D, Pisani A, Bernardi G. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease. Exp Neurol 1999; 158:97-108.
87. Centonze D, Marfia GA, Pisani A, Picconi B, Giacomini P, Bernardi G, et al. Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons. Prog Neurobiol 2001; 6:687-696.
88. Memezawa H, Smith M-L, Siesjo BK. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 1992; 23:552-559.
89. Tagaya M, Haring H-P, Stuiver I, Wagner S, Abumiya T, Lucero J, et al. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab 2001; 21:835-846.
90. Wagner S, Tagaya M, Koziol JA, Quaranta V, del Zoppo GJ. Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin α6β4 during focal cerebral ischemia/reperfusion. Stroke 1997; 28:858-865.